Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Khalil El Karoui's publication output changed over time?
ScholarIQpublication output · 2009–2023
Output grew0% over the shown period — from 1 works in 2009 to 1 in 2023.
1
2
1
1
1
1
1
2
1
200920102011201520162019202020222023
What are the most-cited papers on Khalil El Karoui?
ScholarIQmost cited works
Lipocalin 2 is essential for chronic kidney disease progression in mice and humans
Amandine Viau, Khalil El Karoui, Denise Laouari, Martine Burtin, Clément Nguyen, Kiyoshi Mori, Évangéline Pillebout, Thorsten Berger, Tak W. Mak, Bertrand Knebelmann, Gérard Friedlander, Jonathan Barasch, Fabiola Terzi
S114430552. 2010399 CitationsOPEN ACCESS
Anti-CTLA4 Antibody–Induced Lupus Nephritis
Fouad Fadel, Khalil El Karoui, Bertrand Knebelmann
New England Journal of Medicine. 2009301 Citations
Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database
Léa Hoisnard, Bénédicte Lebrun‐Vignes, Sébastien Maury, Matthieu Mahévas, Khalil El Karoui, Lydia Roy, Anissa Zarour, Marc Michel, José L. Cohen, Aurélien Amiot, Pascal Claudepierre, P. Wolkenstein, Philippe Grimbert, É. Sbidian
Scientific Reports. 2022182 CitationsOPEN ACCESS
COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment
Khalil El Karoui, An S. De Vriese
Kidney International. 2022154 CitationsOPEN ACCESS
A Clinicopathologic Study of Thrombotic Microangiopathy in IgA Nephropathy
Khalil El Karoui, Gary S. Hill, Alexandre Karras, C. Jacquot, L Moulonguet, O Kourilsky, Véronique Frémeaux‐Bacchi, Michel Delahousse, Jean–Paul Duong Van Huyen, Alexandre Loupy, Patrick Bruneval, Dominique Nochy
Journal of the American Society of Nephrology. 2011151 CitationsOPEN ACCESS
Related on ScholarIQ
Inserm
Institution
Lipocalin 2 is essential for chronic kidney disease progression in mice and humans
Paper
Anti-CTLA4 Antibody–Induced Lupus Nephritis
Paper
Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database
Paper
COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment
Paper
A Clinicopathologic Study of Thrombotic Microangiopathy in IgA Nephropathy
Paper